Palm Beach Weight Loss

Palm Beach Weight Loss operates as a telehealth-focused medical practice serving West Palm Beach, FL and surrounding areas, delivering prescription weight management programs alongside hormone optimization and aesthetic medicine. The clinic's remote consultation model allows patients throughout Florida to access GLP-1 receptor agonist therapies and peptide protocols without requiring in-office visits for initial assessments or ongoing monitoring. This telehealth structure accommodates working professionals and patients with mobility limitations who need medical weight loss intervention but face scheduling or transportation barriers.

The clinic's weight management protocols center on semaglutide and tirzepatide, two glucagon-like peptide-1 receptor agonists that regulate appetite and glucose metabolism through different mechanisms. Semaglutide programs typically begin at 0.25 mg weekly with gradual titration based on tolerance and response, while tirzepatide combines GLP-1 and GIP receptor activation for patients who may benefit from dual incretin pathway modulation. Beyond GLP-1 therapies, Palm Beach Weight Loss incorporates lipotropic injection protocols containing methionine, inositol, and choline to support hepatic fat metabolism during caloric restriction phases. The practice also provides NAD+ supplementation protocols, administered through IV infusion or subcutaneous injection depending on patient preference and treatment goals, to address cellular energy production during metabolic transitions that occur with significant weight reduction.

Hormone therapy services extend the clinic's scope beyond weight management into broader metabolic health optimization. Providers evaluate thyroid function, cortisol patterns, and sex hormone levels that frequently contribute to weight retention and metabolic dysfunction, particularly in perimenopausal and postmenopausal women or men experiencing age-related testosterone decline. Hormone replacement protocols are individualized based on laboratory findings and symptom profiles, with ongoing monitoring conducted through telehealth follow-ups and periodic lab work. The integration of hormone assessment with weight loss treatment allows the clinic to address underlying endocrine factors that may limit response to dietary intervention or peptide therapy alone.

Patients initiating care complete virtual consultations where medical history, current medications, weight loss history, and treatment goals are reviewed before prescriptions are issued. The telehealth format includes video appointments for initial evaluations and follow-up assessments, with secure messaging available for questions between scheduled visits. Medications and injection supplies are shipped directly to patient addresses, and the clinic provides injection technique instruction through video demonstration for patients new to self-administration. This remote care model requires patients to obtain baseline laboratory work through local facilities, with results reviewed by providers before treatment initiation and at intervals determined by the specific protocol and individual response patterns.

Palm Beach Weight Loss also maintains primary care services, allowing established weight management patients to address acute medical needs and routine health maintenance within the same practice. This continuity enables providers to consider the full clinical picture when adjusting weight loss medications or hormone therapies, rather than managing these treatments in isolation from other health conditions. The practice's IV therapy menu includes hydration protocols and micronutrient infusions that some patients incorporate during intensive weight loss phases or as part of wellness maintenance routines, though these are adjunctive rather than primary weight management interventions.